Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. April 2026 01:00 ET | Quelle: Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference

Vivoryon attend the Van Lanschot Kempen Life Sciences Conference.
09. April 2026 00:30 ET | Quelle: Custom Market Insights

Global Centrifugal High-Speed Separators Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Austin, TX, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Centrifugal High-Speed Separators Market Size, Trends and Insights By Type...
08. April 2026 20:04 ET | Quelle: Robbins LLP

MEDP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action lawsuit Filed Against Medpace Holdings Inc.

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
08. April 2026 16:50 ET | Quelle: Hagens Berman Sobol Shapiro LLP

INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman

Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
08. April 2026 16:30 ET | Quelle: MacroGenics, Inc.

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study

• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers • On track to provide mid-2026 program update ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) -- MacroGenics,...
08. April 2026 16:16 ET | Quelle: Polyrizon Ltd.

Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements

RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today...
08. April 2026 11:33 ET | Quelle: SNS Insider pvt ltd

Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider

Austin, United States, April 08, 2026 (GLOBE NEWSWIRE) -- SNS Insider reported that global Flow Cytometry Market was valued at USD 5.75 billion in 2025 and is expected to reach USD 12.19 billion by...
08. April 2026 11:03 ET | Quelle: Trogenix

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain...
08. April 2026 09:31 ET | Quelle: 24/7 Market News and Kraig Labs

From Genetic Puzzle to Industrial Platform

Spider silk’s extraordinary combination of strength, elasticity, toughness, biocompatible, biodegradable, and low weight, properties that outperform Kevlar
08. April 2026 09:15 ET | Quelle: Longeveron

Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)

China National Intellectual Property Administration has granted a patent covering potency assay methods for assessing human mesenchymal stem cells (MSCs).

Nächste Seite